Skip to main content
. 2007 Mar 14;40(2):82–91. doi: 10.3164/jcbn.40.82

Fig. 3.

Fig. 3

Model representing putative signaling cascade modulated by chemopreventive agents for induction of phase II enzymes. ROS modulation brought about by chemopreventive agents activate signaling kinases which modify NRF2. Modified NRF2 dissociates from its inhibitor keap1 and translocates to nucleus where it heterodimerizes with other transcription factors and binds to ARE, transactivating down stream genes.